Novartis (NVS) Tops Q3 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- Wall St slips as higher yields and oil prices flag inflation risk
- Oil jumps as Middle East supply concerns persist amid shipping attacks
- Why Citi says the Fed could be setting up for a dovish surprise
- Alphabet shares rise as Google pushes Gemini deeper into enterprise AI
- Lynx sees AI semiconductor rally extending into year-end
Tweet
Share
E-mail
Get Alerts NVS Hot Sheet
Join SI Premium – FREE
Novartis (NYSE: NVS) reported Q3 EPS of $1.29, $0.04 better than the analyst estimate of $1.25. Revenue for the quarter came in at $12.41 billion versus the consensus estimate of $12.25 billion.
2017 Group outlook re-confirmed; net sales expected to be broadly in line with prior year (cc), core operating income expected to be broadly in line or decline low single digit (cc).
For earnings history and earnings-related data on Novartis (NVS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Novagold Resources, Inc. (NG) Misses Q3 EPS by 2c
- AngioDynamics (ANGO) Tops Q1 EPS by 7c, Beats on Revenue; Offers F27 Revenue Guidance
- Starbucks (SBUX) PT Lowered to $105 at UBS as Shares Already Reflect Improved Momentum
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
